FdaApplication
NDA 203414
Identifiers
- fda_app_no: NDA203414
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2013-01-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KAZANO | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE | EQ 12.5MG BASE;1GM | TABLET;ORAL |
| KAZANO | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE | EQ 12.5MG BASE;500MG | TABLET;ORAL |
2 products